Paradigm Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-15,500
| Closed | -$668K | – | 505 |
|
|
2017
Q2 | $668K | Sell |
15,500
-16,000
| -51% | -$690K | 0.13% | 163 |
|
|
2017
Q1 | $986K | Sell |
31,500
-3,000
| -9% | -$93.9K | 0.19% | 121 |
|
|
2016
Q4 | $871K | Sell |
34,500
-1,000
| -3% | -$25.3K | 0.17% | 110 |
|
|
2016
Q3 | $878K | Buy |
35,500
+30,750
| +647% | +$760K | 0.15% | 107 |
|
|
2016
Q2 | $96.8K | Hold |
4,750
| – | – | 0.02% | 460 |
|
|
2016
Q1 | $72.4K | Sell |
4,750
-9,300
| -66% | -$142K | 0.01% | 517 |
|
|
2015
Q4 | $189K | Sell |
14,050
-2,800
| -17% | -$37.6K | 0.03% | 366 |
|
|
2015
Q3 | $236K | Buy |
+16,850
| New | +$236K | 0.03% | 443 |
|